Apr 24 |
Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Mar 26 |
Mural Oncology plc GAAP EPS of -$3.57
|
Mar 26 |
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update
|
Mar 5 |
Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
|
Mar 4 |
Recent Spin Mural Oncology At An Attractive Discount To Cash And Portfolio Value
|
Feb 27 |
Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference
|
Feb 5 |
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Jan 8 |
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
|
Nov 20 |
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
|